Discovery & Development

Statisticians are vital in the pharma industry, but rarely do they receive public fanfare for their work. The Award for Statistical Excellence in the Pharmaceutical Industry aims to change the status quo.

A new technique allows scientists to see conformational changes caused by ligand binding in real time, opening up new screening options for drug discovery.

Pharma companies are notoriously protective of their intellectual property, so it’s a big deal to open up and give knowledge away for free. Nevertheless, it is the path that LEO Pharma took with its Open Innovation platform – and they’ve learnt that, if you give a little away, you can expect much in return.

The drug delivery field may be about to see dramatic shifts in accepted modalities. Nanoparticles, targeted delivery systems and a move from oral to transdermal routes will all play a part in tomorrow’s drug delivery landscape.

Glass is the most important primary packaging material for injectable drugs, but the demanding requirements of today’s sensitive biologicals mean that we must consider newer, safer alternatives.

Could light-activated quantum dots put the “antibiotic apocalypse” on hold?

Solubility is a key for drug delivery but pipelines are full of compounds with poor solubility.

Samir Mitragotri talks us through his fascination with transdermal delivery.

Kirsty Gapp delves into trends and the benefits driving Transdermal and Microneedle Drug Delivery.

With clinical trials under way, the commercialization of a microneedle patch is widely anticipated.